Status:
WITHDRAWN
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsies, Partial
Eligibility:
All Genders
16-70 years
Phase:
PHASE2
PHASE3
Brief Summary
This study will evaluate the effectiveness and safety of seletracetam when it is used in addition to other anti-epileptic medications by patients with partial onset seizures. It will also help to dete...
Eligibility Criteria
Inclusion
- Subjects from 16 to 70 years old
- Confirmed diagnosis of focal epilepsy
- Partial seizures uncontrolled while taking 1 or 2 AEDs
- At least 8 partial seizures during the 8-week baseline period
Exclusion
- Seizures occurring only in clusters
- Status epilepticus within 1 year
- Progressive CNS disorder
- Other serious or uncontrolled diseases
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00422110
Start Date
May 1 2008
Last Update
May 28 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.